KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Return on Sales (2016 - 2025)

Historic Return on Sales for Cme (CME) over the last 17 years, with Q3 2025 value amounting to 0.59%.

  • Cme's Return on Sales rose 100.0% to 0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.58% for FY2024, which is 0.0% changed from last year.
  • Per Cme's latest filing, its Return on Sales stood at 0.59% for Q3 2025, which was up 100.0% from 0.61% recorded in Q2 2025.
  • Cme's 5-year Return on Sales high stood at 0.83% for Q3 2021, and its period low was 0.43% during Q2 2021.
  • In the last 5 years, Cme's Return on Sales had a median value of 0.57% in 2023 and averaged 0.57%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 4500bps in 2021, then plummeted by -2800bps in 2022.
  • Quarter analysis of 5 years shows Cme's Return on Sales stood at 0.54% in 2021, then dropped by -3bps to 0.53% in 2022, then increased by 7bps to 0.57% in 2023, then rose by 1bps to 0.57% in 2024, then rose by 3bps to 0.59% in 2025.
  • Its Return on Sales stands at 0.59% for Q3 2025, versus 0.61% for Q2 2025 and 0.58% for Q1 2025.